Prevalence of Airflow Obstruction in U.S. Adults Aged 40–79 Years: NHANES Data 1988–1994 and 2007–2010

References

• World Health Organization (WHO). Chronic obstructive pulmonary disease (COPD) Fact sheet [Online]. Nov 2012. Available from: http://www.who.int/mediacentre/factsheets/fs315/en/index.html.
   Google Scholar
• National Heart, Lung, and Blood Institute. Morbidity and mortality 2012 chartbook on cardiovascular, lung, and blood diseases. Bethesda, MD: U.S. Department of Health and Human Services, Public Health Service. National Institute of Health. Available from: http://www.nhlbi.nih.gov/research/reports/2012-mortality-chart-book.htm.
   Google Scholar
• Snider JT, Romley JA, Wong KS, Zhang J, Eber M, Goldman DP. The disability burden of COPD. COPD 2012; 9: 513–521.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC). Chronic obstructive disease among adults—United States, 2011. MMWR Surveill Summ 2012; 61:938–943.
   Google Scholar
• Akazawa M, Halpern R, Riedel AA, Stanford RH, Dalal A, Blanchette CM. Economic burden prior to COPD diagnosis: a matched case-control study in the United States. Respir Med 2008; 102:1744–1752.
   PubMed Web of Science ®Google Scholar
• National Heart, Lung, and Blood Institute. Morbidity and mortality 2009 chartbook on cardiovascular, lung, and blood diseases. Bethesda, MD: U.S. Department of Health and Human Services, Public Health Service. National Institute of Health. 2009. Available from: http://www.docin.com/p-419824684.html
   Google Scholar
• Agaku I, King B, Dube SR. Current cigarette smoking among adults—United States, 2011. MMWR 2012; 61(44): 889–894.
   PubMedGoogle Scholar
• Syamlal G, Mazurek JM, Malarcher AM. Current cigarette smoking prevalence among working adults—United States, 2004—2010. MMWR 2011; 60(38):1305–1309.
   PubMedGoogle Scholar
• Global Initiative for Chronic Obstructive Lung Disease, Inc. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, Updated 2013. Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2013_Feb20.pdf (accessed February 26, 2013).
   Google Scholar
• Ford ES, Mannino DM, Wheaton AG, Giles WH, Presley-Cantrell L, Croft JB. Trends in the prevalence of obstructive and restrictive lung function among adults in the United States: findings from the National Health and Nutrition Examination Survey from 1988–1994 to 2007–2010. Chest 2013; 143(5):1395–1406.
   PubMed Web of Science ®Google Scholar
• Barnes TA, Fromer L. Spirometry use: detection of chronic obstructive pulmonary disease in the primary care setting. Clin Interven Aging 2011; 6:47–52.
   PubMed Web of Science ®Google Scholar
• Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J. Interpretative strategies for lung function tests. Eur Respir J 2005; 26:948–968.
   PubMed Web of Science ®Google Scholar
• Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinkski J, Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease GOLD executive summary. Am J Respir Crit Care Med 2007; 176:532–555.
   PubMed Web of Science ®Google Scholar
• Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007; 370:765–773.
   PubMed Web of Science ®Google Scholar
• Hnizdo E, Glindmeyer HW, Petsonk EL, Enright P, Buist AS. Case definitions for chronic obstructive pulmonary disease. COPD 2006; 3:95–100.
   PubMedGoogle Scholar
• Medbo A, Melbye H. Lung function testing in the elderly— can we still use FEV1/FVC < 70% as a criterion of COPD? Respir Med 2007; 101:1097–1105.
   PubMed Web of Science ®Google Scholar
• Swanney MP, Ruppel G, Enright PL Pedersen OF, Crapo RO, et Miller MR, Jensen RL, Falaschetti E, Schouten JP, Hankinson JL, Stocks J, Quanjer PH. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax 2008; 63:1046–1051.
   PubMed Web of Science ®Google Scholar
• Miller MR, Quanjer PH, Swanney MP Ruppel G, Enright PL. Interpreting lung function data using 80% predicted and fixed threshold misclassifies more than 20% of patients. Chest 2011; 139:52–59.
   PubMed Web of Science ®Google Scholar
• Hankinson JL, Odencrantz Jr, Fedan KB. Spirometric reference valuses from a sample of the general US population. Am J Respir Crit Care Med 1999; 159:179–187.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). The national health and nutrition examination survey: sample design, 1999–2006. 2012. Available from: http://www.cdc.gov/nchs/data/series/sr_02/sr02_155.pdf (accessed March 25, 2013).
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Continuous NHANES web tutorial, age standardization and population counts. 2013. Available from: http://www.cdc.gov/nchs/tutorials/NHANES/NHANESAnalyses/agestandardization/age_standardization_intro.htm (accessed April 12, 2013).
   Google Scholar
• Centers for Disease Control and Prevention (CDC). NHANES Spirometry Exam Manual. 2008. Available from: http://www.cdc.gov/nchs/data/nhanes/nhanes_07_08/spirometry.pdf (accessed April 12, 2013).
   Google Scholar
• Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J 2005; 26:319–338.
   PubMed Web of Science ®Google Scholar
• Hankinson JL, Kawut SM, Shahar E, mith LJ, Stukovsky KH, Barr RG. Performance of American Thoracic Society-recommended spirometry reference values in a multiethnic sample of adults the Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study. Chest 2010; 137:138–145.
   PubMed Web of Science ®Google Scholar
• SAS Institute Inc. 2011. Base SAS 9.3 Procedures Guide: Statistical Procedures. Cary, NC: SAS Institute Inc.
   Google Scholar
• Klein RJ, Schoenborn, CA. Age adjustment using the 2000 projected U.S. population. Health People Statistical Notes, no. 20. Hyattsville, Maryland: National Center for Health Statistics. 2001.
   Google Scholar
• CPS Current Population Survey. 2011. Available from: http://www.census.gov/cps (accessed August 1, 2012).
   Google Scholar
• Kochanek KE, Xu J, Murphy SL, Minino AM, Kung H. Deaths: final data for 2009. Natl Vital Stat Rep 2011; 60(3):1–116.
   PubMedGoogle Scholar
• Huertas A, Lalange P. COPD a multifactorial systemic disease. Therapeutic Adv Respir Dis 2011; 5(3):217–224.
   PubMedGoogle Scholar
• Huertas A, Lalange P. circulating endothelial progenitor cells and chronic pulmonary diseases. Eur Respir J 2011; 37:426–431.
   PubMed Web of Science ®Google Scholar
• Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 2005: 127:1952–1959.
   PubMed Web of Science ®Google Scholar
• CDC/NCHS, Health Data Interactive and National Health Interview Survey, 2007–2009. [Online] Available from: http://205.207.175.93/HDI/ReportFolders/reportFolders.aspx (accessed April 15, 2013).
   Google Scholar
• Koefoed MM, Christensen RD, Sondergaard J, Jarbol DE. Lack of spirometry use in Danish patients initiating medication targeting obstructive lung disease. Respir Med 2012; 106:1743–1748.
   PubMed Web of Science ®Google Scholar
• Laden F, Schwartz J, Speizer FE, Dockery DW. Reduction in fine particulate air pollution and mortality extended follow-up of the Harvard Six Cities Study. Am J Respir Crit Care Med 2006; 173:667–672.
   PubMed Web of Science ®Google Scholar
• Pope CA III, Dockery DW. Health effect of fine particulate air pollution: lines that connect. J Air Waste Mgmt Assoc 2006; 56(6):709–742.
   PubMedGoogle Scholar
• Sterk PJ. Let's not forget: the GOLD criteria for COPD are based on post-bronchodilator FEV1. Eur Respir J 2004; 23:497–498.
   PubMed Web of Science ®Google Scholar
• Johannessen A, Omenaas ER, Bakke PS, Gulsvik A. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax 2005; 60:842–847.
   PubMed Web of Science ®Google Scholar
• Perez-Padilla R, Hallal PD, Vazquez-Garcia JC, M·rquez MN, Jardim JR, PertuzÈ J, Lisboa C, MuiÒo A, LÛpez MV, T·lamo C, de Oca MM, Valdivia G, Menezes AM, Latin American COPD Prevalence Study (PLATINO) Team. Impact of broncholdilator use on the prevalence of COPD in population-based samples. COPD 2007; 4:113–120.
   PubMedGoogle Scholar
• Tashkin DP, Ceilli B, Decramer M, Liu D, Burkhart D, Cassino C, Kesten S. Bronchodilator responsiveness in patients with COPD. Eur Respir J 2008; 31:742–750.
   PubMed Web of Science ®Google Scholar
• Quanjer PH, Stanojevic S, Cole TJ, Baur X, Halll GL, Culver BH, Enright PL, Hankinson JL, Ip MS, Zheng J, Stocks J, ERS Global Lung Function Initiative. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur Respir J 2012; 40:1324–1343.
   PubMed Web of Science ®Google Scholar